IMGN vs CLVS | IMGN Message Board Posts

ImmunoGen, Inc.

  IMGN website

IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  49766 of 49859  at  8/13/2019 3:04:25 PM  by

Bibliobiftek


 In response to msg 49765 by  Biotechbeagle
view thread

Re: IMGN vs CLVS

In addition to that, Clovis still has the pall of overhyped rociletinib results hanging over it. The management pumped share prices based on early but unconfirmed ORR reports which did not translate into confirmed ORR, and osimeritinib ran away with the EGFR-790m NSCLC category in the end. They also have a lot convertible debt on the books which will make for a lot of dilution in just a few years, whereas Immunogen has a cleaner balance sheet but still a very fast burn rate.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 298
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...